| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.19 | 4e-07 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-05 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.32 | 0.0001 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.6 | 0.0002 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0003 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.22 | 0.0004 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.21 | 0.0005 |